Pasithea therapeutics postpones special meeting until december 9, 2022 at 9:00 am eastern time

Miami beach, fla., nov. 28, 2022 (globe newswire) -- pasithea therapeutics corp. (nasdaq: ktta) (“pasithea” or the “company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (“cns”) disorders, today announced that it has postponed its special stockholder meeting (the “special meeting”) originally scheduled for november 29, 2022 to allow additional time for stockholder voting proxies (the “notice”).
KTTA Ratings Summary
KTTA Quant Ranking